tiprankstipranks
pc:neokb

NEOK Bio

NEOK Bio, Inc. is a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) that are designed to improve outcomes for cancer patients. NEOK is rapidly advancing bispecific ADCs which represent a cutting-edge advancement, leveraging bispecific antibodies that target two complimentary antigens, potentially improving safety while enhancing the efficacy of ADCs in a wider range of tumors.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$75M
Total Amount Raised$75M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$75M
Latest Funding Amount$75M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 04, 2025
Series A
$75.00M

Investors

Investor Name
Funding Round

Related News and Analysis